|
|
| Research article summary (published 30 Jul 2009): |
Classification of therapy resistance based on longitudinal biomarker profiles.
Full Abstract
To classify patients either as resistant or non-resistant to HIV therapy based on longitudinal viral load profiles, we applied longitudinal quadratic discriminant analysis and examined various measures, mainly derived from the Brier Score, to assess the biomarker performance in terms of discrimination and calibration. The analysis of the application data revealed an increase in performance by using longer profiles instead of single biomarker measurements. Simulations showed that the selection of mixed models for the estimation of the group-specific discriminant rule parameters should be based on BIC, rather than on the best performance measure. An incorrect model selection can lead to spuriously better or worse performance as misclassification and classification certainty regards, especially with increasing length of the profiles and for more complex models with random slopes.
Author information
Author/s: Kohlmann, Mareike (M); Held, Leonhard (L); Grunert, Veit Peter (VP);
Affiliation: Institute of Statistics, Ludwig-Maximilians University, 80539 Munich, Germany.
Journal and publication information
Publication Type: Journal Article
Journal: Biometrical journal. Biometrische Zeitschrift (Biom J), published in Germany. (Language: eng)
Reference: 2009-Aug; vol 51 (issue 4) : pp 610-26
Dates: Created 2009/08/24; Completed 2009/11/05;
PMID: 19688757, status: MEDLINE (last retrieved date: 11/5/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Anti-HIV Agents (0) ; Biological Markers (0)Related articles
These are the most related articles currently in our database:
- Serum malondialdehyde correlates with therapeutic efficiency of high activity antiretroviral therapies (HAART) in HIV-1 infected children.
27 Feb 2002 - Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.
27 Mar 2002 - Surveillance of CD4 counts in known HIV-infected people--a paradigm for the era of highly active antiretroviral therapy.
27 Feb 2001 - Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
13 Dec 2004 - Special report: the aging AIDS epidemic. New face of HIV/AIDS presents challenges and new comorbidities. Experts discuss the future of the epidemic.
30 Aug 2004 - HIV drug resistance.
2 Mar 2004 - A prospective, cross-sectional study of anaemia and peripheral iron status in antiretroviral naïve, HIV-1 infected children in Cape Town, South Africa.
9 Feb 2002 - Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
29 Sep 1996 - Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
28 Feb 2000 - Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.
30 Dec 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.